BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anasir MI, Ramanathan B, Poh CL. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus. Viruses 2020;12:E367. [PMID: 32225021 DOI: 10.3390/v12040367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Taldaev A, Terekhov R, Nikitin I, Zhevlakova A, Selivanova I. Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling. Int J Mol Sci 2022;23:6023. [PMID: 35682702 DOI: 10.3390/ijms23116023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zarif F, Anasir MI, Koh JX, Chew MF, Poh CL. Stability and antiviral activity of SP40 peptide in human serum. Virus Res 2021;303:198456. [PMID: 34314773 DOI: 10.1016/j.virusres.2021.198456] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Racherla RG, Katari SK, Mohan A, Amineni U, Badur M, Chaudhury A, Nagaraja M, Kodavala S, Kante M, Kalawat U. Molecular Characterization and Identification of Potential Inhibitors for 'E' Protein of Dengue Virus. Viruses 2022;14:940. [PMID: 35632682 DOI: 10.3390/v14050940] [Reference Citation Analysis]
4 Wang R, Lu J, Chen L, Yu Y, Yang Z. A human bispecific neutralization antibody against four serotypes of dengue virus. Virology 2021;558:49-56. [PMID: 33721729 DOI: 10.1016/j.virol.2021.01.009] [Reference Citation Analysis]
5 Sahasrabuddhe A, Oakley D, Chen K, McCarter JD. Development of a High-Throughput Affinity Mass Spectrometry (AMS) Platform Using Laser Diode Thermal Desorption Ionization Coupled to Mass Spectrometry (LDTD-MS). SLAS Discov 2021;26:230-41. [PMID: 33334237 DOI: 10.1177/2472555220979596] [Reference Citation Analysis]
6 Chen WC, Wei CK, Hossen M, Hsu YC, Lee JC. (E)-Guggulsterone Inhibits Dengue Virus Replication by Upregulating Antiviral Interferon Responses through the Induction of Heme Oxygenase-1 Expression. Viruses 2021;13:712. [PMID: 33924157 DOI: 10.3390/v13040712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Recalde-reyes DP, Rodríguez-salazar CA, Castaño-osorio JC, Giraldo-giraldo MI. PD1 CD44 Antiviral Peptide as an Inhibitor of the Protein-Protein Interaction in Dengue Virus Invasion. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170797] [Reference Citation Analysis]
8 Cordero-Rivera CD, De Jesús-González LA, Osuna-Ramos JF, Palacios-Rápalo SN, Farfan-Morales CN, Reyes-Ruiz JM, Del Ángel RM. The importance of viral and cellular factors on flavivirus entry. Curr Opin Virol 2021;49:164-75. [PMID: 34171540 DOI: 10.1016/j.coviro.2021.05.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Ahmad F, Albutti A, Tariq MH, Din G, Tahir Ul Qamar M, Ahmad S. Discovery of Potential Antiviral Compounds against Hendra Virus by Targeting Its Receptor-Binding Protein (G) Using Computational Approaches. Molecules 2022;27:554. [PMID: 35056869 DOI: 10.3390/molecules27020554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Cui G, Si L, Wang Y, Zhou J, Yan H, Jiang L. Antibody-dependent enhancement (ADE) of dengue virus: Identification of the key amino acid that is vital in DENV vaccine research. J Gene Med 2021;23:e3297. [PMID: 33217097 DOI: 10.1002/jgm.3297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Anasir MI, Zarif F, Poh CL. Antivirals blocking entry of enteroviruses and therapeutic potential. J Biomed Sci 2021;28:10. [PMID: 33451326 DOI: 10.1186/s12929-021-00708-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Su Y, Lin T, Liu C, Cheng C, Han X, Jiang X. microRNAs, the Link Between Dengue Virus and the Host Genome. Front Microbiol 2021;12:714409. [PMID: 34456895 DOI: 10.3389/fmicb.2021.714409] [Reference Citation Analysis]